ViroMissile
ViroMissile, Inc.
ViroMissile, Inc. is an innovative biotech company based in California, dedicated to transforming cancer treatment through its groundbreaking IDOV™ (Intravenously Deliverable Oncolytic Virus) platform. Founded in 2018, the company focuses on developing advanced cancer therapies that aim to provide effective, one-time treatments for patients with various cancers, particularly metastatic tumors.
Products & Team
IDOV™ platform
The IDOV™ platform utilizes genetically engineered vaccinia viruses to selectively target and destroy cancer cells while simultaneously activating the body's immune response. This platform enables the delivery of the treatment via intravenous methods, allowing it to reach tumors throughout the body.
IDOV™ provides a potential 'one-shot' cure for various cancers, effectively targeting metastatic tumors and offering hope to patients with limited treatment options.
The need for effective cancer therapies that can overcome limitations of current treatments, such as invasive administration and limited efficacy against metastatic tumors.